Per the White House’s own fact sheet, the executive order does several things. It directs the FDA Commissioner to issue National Priority Vouchers to psychedelic drugs that have already received Breakthrough Therapy designation, which is meant to speed up the review process.
Trump Signed the Psychedelic Order, Now What?
by Brooke Blazr | May 1, 2026 | High Dispatch | 0 comments
